BOSTON , Jan. 06, 2022 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) today announced that it will be attending and presenting at the H.C. Wainwright BioConnect Conference . TransCode’s Chief Executive Officer, Michael Dudley , will describe the Company's RNA-based scientific
